Page last updated: 2024-09-02

cobaltiprotoporphyrin and Leukemia, Lymphocytic, T Cell

cobaltiprotoporphyrin has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamamura, RS; Kobayashi, C; Kurashina, R; Ohyashiki, JH; Ohyashiki, K; Takaku, T; Zhang, Y1

Other Studies

1 other study(ies) available for cobaltiprotoporphyrin and Leukemia, Lymphocytic, T Cell

ArticleYear
Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells.
    British journal of cancer, 2007, Oct-22, Volume: 97, Issue:8

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Boronic Acids; Bortezomib; Electrophoretic Mobility Shift Assay; Gene Expression; Gene Expression Profiling; Heme Oxygenase-1; Humans; I-kappa B Proteins; Leukemia, T-Cell; Mice; NF-kappa B; Oligonucleotide Array Sequence Analysis; Protoporphyrins; Pyrazines; Rats; Reverse Transcriptase Polymerase Chain Reaction

2007